AIHTA - Publications - Search - Fruquintinib (Fruzaqla®) as monotherapy for the treatment of metastatic colorectal cancer (mCRC)

Rothschedl, E. and Grössmann, N. (2024): Fruquintinib (Fruzaqla®) as monotherapy for the treatment of metastatic colorectal cancer (mCRC). Fact Sheet Nr. 171.

[thumbnail of Fact Sheet Nr.171.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
1MB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WI Digestive system > WI 400-560 Intestines
WI Digestive system > WI 600-650 Anus. Rectum
Language:English
Series Name:Fact Sheet Nr. 171
Deposited on:12 Jun 2024 16:04
Last Modified:12 Jun 2024 16:04

Repository Staff Only: item control page